CINRYZE 500 units, powder and solvent for solution for injection 2 bottles of 5 ml
Active ingredients: INHIBITEUR DE C1 HUMAIN
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for injection2 bottles of 5 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CINRYZE 500 unités, poudre et solvant pour solution injectable
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 2 flacon(s) en verre de 500 unité(s) - 2 flacon(s) en verre de 5 ml avec dispositif(s) de transfert avec filtre(s) avec seringue(s) avec nécessaire(s)
- Marketing authorisation holder
- TAKEDA MANUFACTURING AUSTRIA (AUTRICHE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 8 Mar 2013
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
69014721CIP72185630CIP133400921856309Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| INHIBITEUR DE C1 HUMAINpoudre | 500 unités · un flacon de poudre | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.